Publication | Closed Access
A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer
52
Citations
17
References
2009
Year
OncologyHealth SciencesMedicineSynthetic 9-AminoanthracyclinePhase Ii StudyBronchial NeoplasmPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyLung CancerCancer ResearchDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1